Oral Rivaroxaban Versus Standard Therapy in the Initial Treatment of Symptomatic Deep Vein Thrombosis and Long-Term Prevention of Recurrent Venous Thromboembolism - EINSTEIN–DVT


The goal of the trial was to evaluate treatment with the oral direct factor Xa inhibitor rivaroxaban compared with enoxaparin/vitamin K antagonist among patients with acute deep venous thromboembolism.